Fact CheckerSign in

NCT04169542Recruiting

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

Potential Impact of the COVID -19 Pandemic on Financial Toxicity in Breast Cancer Surgical Patients: The Impact on Out of Pocket Costs, Lost Wages and Economic Strain

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.

Status (registry)
Recruiting
Study type
Observational
Enrollment
600 (estimated)
First submitted
18 Nov 2019
Start date
21 May 2019
Primary completion date
31 Mar 2028
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT04169542

What you commit to

  • Study type: Observational
  • Planned participants: 600
  • From 21 May 2019 to the primary completion date, 31 Mar 2028
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Those with recurrent or metastatic disease or concurrent primary cancers
  • Patients undergoing breast conservation therapy will also be excluded from the study

Other

  • Non-English-speaking

Who the study is looking for

  • Have an indication for surgical treatment of invasive breast cancer or ductal breast carcinoma in situ (DCIS) or prophylaxis in the setting of genetic mutations or strong family history
  • English-speaking
  • Able to complete consent
  • Able to fill out computer survey material

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MD Anderson in The Woodlands
Coordinator of this site? Confirm its status
ConroeUnited StatesRecruiting
M D Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting
MD Anderson League City
Coordinator of this site? Confirm its status
League CityUnited StatesRecruiting
MD Anderson in Sugar Land
Coordinator of this site? Confirm its status
Sugar LandUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.